CVS Health CVS and The Cigna Group CI stand as two dominant forces in the U.S. diversified healthcare sector, commanding market capitalizations of approximately $77 billion and $84 billion ...

The Cigna Group is the latest company accused of mismanaging the forfeited funds in its 401(k) plan, and software company Intuit Inc. has reached a settlement after the court had allowed the case to ...

Trump also reiterated his long-standing criticism of companies that own pharmacy benefit managers, like CVS and Cigna, for what he described as their role in distorting drug pricing.

Express Scripts, Cigna, UnitedHealthcare, CVS Health, and Optum Rx have all added Yesintek ... Biocon Biologics has reached a settlement and license agreement with Regeneron, paving the way for the US ...

A witness said this “probably happens,” as the letter (PDF) to CVS details. The committee ... UnitedHealth Group agreed to settle a class-action lawsuit that said the company violated the ...

Self-insured health plans dominate the U.S. employer plan market, and three big health insurers — Elevance, Cigna and CVS Health — dominate the market for administrative services for those ...

UnitedHealth, Cigna, and CVS own three of the largest PBMs in the country. However, there is a startling lack of transparency when it comes to how PBMs operate behind the scenes, notes the Center ...

CVS Health's Caremark, Cigna's Express Scripts and UnitedHealth's OptumRx are the three largest PBMs. Ready to turn the market’s comeback into steady cash flow? Grab the top 3 stocks to buy ...

CVS, Cigna and UnitedHealth are suing the Federal Trade Commission in a bid to block the agency’s lawsuit against their pharmacy benefit managers for allegedly inflating U.S. insulin prices.

Pharmacy benefit managers owned by Cigna (NYSE:CI), CVS Heath (NYSE:CVS), and UnitedHealth Group (NYSE:UNH) have sued the Federal Trade Commission, arguing that a case the agency has filed against ...

CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.